In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.
about
DNA polymerase γ and disease: what we have learned from yeastMitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic optionsDevelopment of pharmacological strategies for mitochondrial disorders.Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome.Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.Towards a therapy for mitochondrial disease: an update
P2860
In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In vitro supplementation with ...... s mitochondrial DNA depletion.
@en
In vitro supplementation with ...... s mitochondrial DNA depletion.
@nl
type
label
In vitro supplementation with ...... s mitochondrial DNA depletion.
@en
In vitro supplementation with ...... s mitochondrial DNA depletion.
@nl
prefLabel
In vitro supplementation with ...... s mitochondrial DNA depletion.
@en
In vitro supplementation with ...... s mitochondrial DNA depletion.
@nl
P2093
P2860
P50
P1476
In vitro supplementation with ...... s mitochondrial DNA depletion.
@en
P2093
Elke Holinski-Feder
Maggie C Walter
Sabine Krause
Stefanie Bulst
P2860
P304
P356
10.1016/J.YMGME.2012.04.022
P577
2012-05-03T00:00:00Z